JENBURKT PHARMACEUTICALS
Back to Balance Sheet
|
JENBURKT PHARMACEUTICALS Last 5 Year Total Non-Current Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹4.12 Cr | ₹2.98 Cr | ₹3.24 Cr | ₹3.92 Cr | ₹3.99 Cr |
What is the latest Total Non-Current Liabilities ratio of JENBURKT PHARMACEUTICALS ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹4.12 Cr |
| Mar2024 | ₹2.98 Cr |
| Mar2023 | ₹3.24 Cr |
| Mar2022 | ₹3.92 Cr |
| Mar2021 | ₹3.99 Cr |
How is Total Non-Current Liabilities of JENBURKT PHARMACEUTICALS Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹4.12 Cr | 38.12 | |
| Mar2024 | ₹2.98 Cr | -7.82 | |
| Mar2023 | ₹3.24 Cr | -17.36 | |
| Mar2022 | ₹3.92 Cr | -1.81 | |
| Mar2021 | ₹3.99 Cr | - | |
Compare Total Non-Current Liabilities of peers of JENBURKT PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| JENBURKT PHARMACEUTICALS | ₹469.8 Cr | -3.3% | -5.8% | -3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹408,991.0 Cr | 0.1% | -3.2% | -2.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹162,371.0 Cr | -1.5% | -7.3% | 2.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹135,229.0 Cr | -1.3% | -0.7% | 24.4% | Stock Analytics | |
| CIPLA | ₹108,441.0 Cr | 1.5% | -8.1% | -6.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,407.0 Cr | 3.2% | 5.6% | 3.1% | Stock Analytics | |
JENBURKT PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| JENBURKT PHARMACEUTICALS | -3.3% |
-5.8% |
-3% |
| SENSEX | 2.9% |
-1.1% |
8.5% |
You may also like the below Video Courses